Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Angiogenic and Arthritogenic Properties of the Soluble Form of CD13.

Du Y, Lu C, Morgan RL, Stinson WA, Campbell PL, Cealey E, Fu W, Lepore NJ, Hervoso JL, Cui H, Urquhart AG, Lawton JN, Chung KC, Fox DA, Amin MA.

J Immunol. 2019 Jul 15;203(2):360-369. doi: 10.4049/jimmunol.1801276. Epub 2019 Jun 12.

PMID:
31189572
2.

5-Aryl-1,3,4-oxadiazol-2-ylthioalkanoic Acids: A Highly Potent New Class of Inhibitors of Rho/Myocardin-Related Transcription Factor (MRTF)/Serum Response Factor (SRF)-Mediated Gene Transcription as Potential Antifibrotic Agents for Scleroderma.

Kahl DJ, Hutchings KM, Lisabeth EM, Haak AJ, Leipprandt JR, Dexheimer T, Khanna D, Tsou PS, Campbell PL, Fox DA, Wen B, Sun D, Bailie M, Neubig RR, Larsen SD.

J Med Chem. 2019 May 9;62(9):4350-4369. doi: 10.1021/acs.jmedchem.8b01772. Epub 2019 Apr 18.

3.

Citrullinated Inhibitor of DNA Binding 1 Is a Novel Autoantigen in Rheumatoid Arthritis.

Ohara RA, Edhayan G, Rasmussen SM, Isozaki T, Remmer HA, Lanigan TM, Campbell PL, Urquhart AG, Lawton JN, Chung KC, Fox DA, Ruth JH.

Arthritis Rheumatol. 2019 Mar 12. doi: 10.1002/art.40886. [Epub ahead of print]

PMID:
30861322
4.

A unique role for galectin-9 in angiogenesis and inflammatory arthritis.

O'Brien MJ, Shu Q, Stinson WA, Tsou PS, Ruth JH, Isozaki T, Campbell PL, Ohara RA, Koch AE, Fox DA, Amin MA.

Arthritis Res Ther. 2018 Feb 12;20(1):31. doi: 10.1186/s13075-018-1519-x.

5.

Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-α Inhibition for Cancer and Autoimmune Disease.

Totzke J, Gurbani D, Raphemot R, Hughes PF, Bodoor K, Carlson DA, Loiselle DR, Bera AK, Eibschutz LS, Perkins MM, Eubanks AL, Campbell PL, Fox DA, Westover KD, Haystead TAJ, Derbyshire ER.

Cell Chem Biol. 2017 Aug 17;24(8):1029-1039.e7. doi: 10.1016/j.chembiol.2017.07.011.

6.

Pharmacokinetic optimitzation of CCG-203971: Novel inhibitors of the Rho/MRTF/SRF transcriptional pathway as potential antifibrotic therapeutics for systemic scleroderma.

Hutchings KM, Lisabeth EM, Rajeswaran W, Wilson MW, Sorenson RJ, Campbell PL, Ruth JH, Amin A, Tsou PS, Leipprandt JR, Olson SR, Wen B, Zhao T, Sun D, Khanna D, Fox DA, Neubig RR, Larsen SD.

Bioorg Med Chem Lett. 2017 Apr 15;27(8):1744-1749. doi: 10.1016/j.bmcl.2017.02.070. Epub 2017 Mar 10.

7.

Experimental sadness induces relevant interactions between central endogenous opioid activation and plasma IL-18 concentrations in depressed volunteers.

Prossin AR, Koch AE, Campbell PL, Barichello T, Zalcman SS, Zubieta JK.

Mol Psychiatry. 2016 Feb;21(2):151. doi: 10.1038/mp.2015.213. No abstract available.

PMID:
26786674
8.

Scleroderma dermal microvascular endothelial cells exhibit defective response to pro-angiogenic chemokines.

Tsou PS, Rabquer BJ, Ohara RA, Stinson WA, Campbell PL, Amin MA, Balogh B, Zakhem G, Renauer PA, Lozier A, Arasu E, Haines GK 3rd, Kahaleh B, Schiopu E, Khanna D, Koch AE.

Rheumatology (Oxford). 2016 Apr;55(4):745-54. doi: 10.1093/rheumatology/kev399. Epub 2015 Dec 24.

9.

Activation of the Thromboxane A2 Receptor by 8-Isoprostane Inhibits the Pro-Angiogenic Effect of Vascular Endothelial Growth Factor in Scleroderma.

Tsou PS, Amin MA, Campbell PL, Zakhem G, Balogh B, Edhayan G, Ohara RA, Schiopu E, Khanna D, Koch AE, Fox DA.

J Invest Dermatol. 2015 Dec;135(12):3153-3162. doi: 10.1038/jid.2015.323. Epub 2015 Aug 19.

10.

Acute experimental changes in mood state regulate immune function in relation to central opioid neurotransmission: a model of human CNS-peripheral inflammatory interaction.

Prossin AR, Koch AE, Campbell PL, Barichello T, Zalcman SS, Zubieta JK.

Mol Psychiatry. 2016 Feb;21(2):243-51. doi: 10.1038/mp.2015.110. Epub 2015 Aug 18.

11.

Inflammatory properties of inhibitor of DNA binding 1 secreted by synovial fibroblasts in rheumatoid arthritis.

Edhayan G, Ohara RA, Stinson WA, Amin MA, Isozaki T, Ha CM, Haines GK 3rd, Morgan R, Campbell PL, Arbab AS, Friday SC, Fox DA, Ruth JH.

Arthritis Res Ther. 2016 Apr 12;18:87. doi: 10.1186/s13075-016-0984-3.

12.

Dynamic interactions between plasma IL-1 family cytokines and central endogenous opioid neurotransmitter function in humans.

Prossin AR, Zalcman SS, Heitzeg MM, Koch AE, Campbell PL, Phan KL, Stohler CS, Zubieta JK.

Neuropsychopharmacology. 2015 Feb;40(3):554-65. doi: 10.1038/npp.2014.202. Epub 2014 Aug 20.

13.

Citrullination of epithelial neutrophil-activating peptide 78/CXCL5 results in conversion from a non-monocyte-recruiting chemokine to a monocyte-recruiting chemokine.

Yoshida K, Korchynskyi O, Tak PP, Isozaki T, Ruth JH, Campbell PL, Baeten DL, Gerlag DM, Amin MA, Koch AE.

Arthritis Rheumatol. 2014 Oct;66(10):2716-27. doi: 10.1002/art.38750.

14.

Fucosyltransferase 1 mediates angiogenesis in rheumatoid arthritis.

Isozaki T, Amin MA, Ruth JH, Campbell PL, Tsou PS, Ha CM, Stinson WA, Domino SE, Koch AE.

Arthritis Rheumatol. 2014 Aug;66(8):2047-58. doi: 10.1002/art.38648.

15.

A key role for Fut1-regulated angiogenesis and ICAM-1 expression in K/BxN arthritis.

Amin MA, Campbell PL, Ruth JH, Isozaki T, Rabquer BJ, Alex Stinson W, O'Brien M, Edhayan G, Ohara RA, Vargo J, Domino SE, Koch AE.

Ann Rheum Dis. 2015 Jul;74(7):1459-66. doi: 10.1136/annrheumdis-2013-204814. Epub 2014 Mar 24.

PMID:
24665114
16.

Fucosyltransferase 1 mediates angiogenesis, cell adhesion and rheumatoid arthritis synovial tissue fibroblast proliferation.

Isozaki T, Ruth JH, Amin MA, Campbell PL, Tsou PS, Ha CM, Haines GK, Edhayan G, Koch AE.

Arthritis Res Ther. 2014 Jan 28;16(1):R28. doi: 10.1186/ar4456.

17.

A novel role for inducible Fut2 in angiogenesis.

Tsou PS, Ruth JH, Campbell PL, Isozaki T, Lee S, Marotte H, Domino SE, Koch AE, Amin MA.

Angiogenesis. 2013 Jan;16(1):195-205. doi: 10.1007/s10456-012-9312-y. Epub 2012 Oct 12.

18.

Suppression of endothelial cell activity by inhibition of TNFα.

Shu Q, Amin MA, Ruth JH, Campbell PL, Koch AE.

Arthritis Res Ther. 2012 Apr 25;14(2):R88. doi: 10.1186/ar3812.

19.

Association of plasma interleukin-18 levels with emotion regulation and μ-opioid neurotransmitter function in major depression and healthy volunteers.

Prossin AR, Koch AE, Campbell PL, McInnis MG, Zalcman SS, Zubieta JK.

Biol Psychiatry. 2011 Apr 15;69(8):808-12. doi: 10.1016/j.biopsych.2010.10.014. Epub 2010 Dec 9.

PMID:
21145535
20.

Green tea extract inhibits chemokine production, but up-regulates chemokine receptor expression, in rheumatoid arthritis synovial fibroblasts and rat adjuvant-induced arthritis.

Marotte H, Ruth JH, Campbell PL, Koch AE, Ahmed S.

Rheumatology (Oxford). 2010 Mar;49(3):467-79. doi: 10.1093/rheumatology/kep397. Epub 2009 Dec 23.

21.

Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production.

Ahmed S, Marotte H, Kwan K, Ruth JH, Campbell PL, Rabquer BJ, Pakozdi A, Koch AE.

Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14692-7. doi: 10.1073/pnas.0802675105. Epub 2008 Sep 16.

22.

Monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha as possible biomarkers for the chronic pelvic pain syndrome.

Desireddi NV, Campbell PL, Stern JA, Sobkoviak R, Chuai S, Shahrara S, Thumbikat P, Pope RM, Landis JR, Koch AE, Schaeffer AJ.

J Urol. 2008 May;179(5):1857-61; discussion 1861-2. doi: 10.1016/j.juro.2008.01.028. Epub 2008 Mar 18.

23.

Interleukin-18 induces angiogenic factors in rheumatoid arthritis synovial tissue fibroblasts via distinct signaling pathways.

Amin MA, Mansfield PJ, Pakozdi A, Campbell PL, Ahmed S, Martinez RJ, Koch AE.

Arthritis Rheum. 2007 Jun;56(6):1787-97.

24.

CXCL16-mediated cell recruitment to rheumatoid arthritis synovial tissue and murine lymph nodes is dependent upon the MAPK pathway.

Ruth JH, Haas CS, Park CC, Amin MA, Martinez RJ, Haines GK 3rd, Shahrara S, Campbell PL, Koch AE.

Arthritis Rheum. 2006 Mar;54(3):765-78.

25.

Chemokine receptor expression in rat adjuvant-induced arthritis.

Haas CS, Martinez RJ, Attia N, Haines GK 3rd, Campbell PL, Koch AE.

Arthritis Rheum. 2005 Dec;52(12):3718-30.

26.

The effect of sulfasalazine on rheumatoid arthritic synovial tissue chemokine production.

Volin MV, Campbell PL, Connors MA, Woodruff DC, Koch AE.

Exp Mol Pathol. 2002 Oct;73(2):84-92.

PMID:
12231210
27.
28.

Reduction of inflammatory cytokines and prostaglandin E2 by IL-13 gene therapy in rheumatoid arthritis synovium.

Woods JM, Katschke KJ Jr, Tokuhira M, Kurata H, Arai KI, Campbell PL, Koch AE.

J Immunol. 2000 Sep 1;165(5):2755-63.

29.

IL-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis.

Nadler RB, Koch AE, Calhoun EA, Campbell PL, Pruden DL, Bennett CL, Yarnold PR, Schaeffer AJ.

J Urol. 2000 Jul;164(1):214-8.

PMID:
10840462
30.

Ley/H: an endothelial-selective, cytokine-inducible, angiogenic mediator.

Halloran MM, Carley WW, Polverini PJ, Haskell CJ, Phan S, Anderson BJ, Woods JM, Campbell PL, Volin MV, Bäcker AE, Koch AE.

J Immunol. 2000 May 1;164(9):4868-77.

31.

Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions.

Hochreiter WW, Nadler RB, Koch AE, Campbell PL, Ludwig M, Weidner W, Schaeffer AJ.

Urology. 2000 Dec 20;56(6):1025-9.

PMID:
11113752
32.

Treatment with sulfasalazine or sulfapyridine, but not 5-aminosalicyclic acid, inhibits basic fibroblast growth factor-induced endothelial cell chemotaxis.

Volin MV, Harlow LA, Woods JM, Campbell PL, Amin MA, Tokuhira M, Koch AE.

Arthritis Rheum. 1999 Sep;42(9):1927-35.

33.

Rapid in situ harvesting and cytogenetic analysis of perinatal tissue samples.

Fisher AM, Cockwell AE, Moore KJ, Gregson NM, Campbell PL, Campbell CM, Herbert A, Barber JC, Crolla JA.

Prenat Diagn. 1996 Jul;16(7):615-21.

PMID:
8843470
34.

A case of maternal uniparental disomy of chromosome 9 in association with confined placental mosaicism for trisomy 9.

Wilkinson TA, James RS, Crolla JA, Cockwell AE, Campbell PL, Temple IK.

Prenat Diagn. 1996 Apr;16(4):371-4.

PMID:
8734817
35.

Unbalanced translocation in a mother and her son in one of two 5;10 translocation families.

Barber JC, Temple IK, Campbell PL, Collinson MN, Campbell CM, Renshaw RM, Dennis NR.

Am J Med Genet. 1996 Mar 1;62(1):84-90.

PMID:
8779332
36.

Molecular characterization of breakpoints in patients with holoprosencephaly and definition of the HPE2 critical region 2p21.

Schell U, Wienberg J, Köhler A, Bray-Ward P, Ward DE, Wilson WG, Allen WP, Lebel RR, Sawyer JR, Campbell PL, Aughton DJ, Punnett HH, Lammer EJ, Kao FT, Ward DC, Muenke M.

Hum Mol Genet. 1996 Feb;5(2):223-9.

PMID:
8824878
37.

The carbonic anhydrase domain of receptor tyrosine phosphatase beta is a functional ligand for the axonal cell recognition molecule contactin.

Peles E, Nativ M, Campbell PL, Sakurai T, Martinez R, Lev S, Clary DO, Schilling J, Barnea G, Plowman GD, Grumet M, Schlessinger J.

Cell. 1995 Jul 28;82(2):251-60.

38.

EEA1, an early endosome-associated protein. EEA1 is a conserved alpha-helical peripheral membrane protein flanked by cysteine "fingers" and contains a calmodulin-binding IQ motif.

Mu FT, Callaghan JM, Steele-Mortimer O, Stenmark H, Parton RG, Campbell PL, McCluskey J, Yeo JP, Tock EP, Toh BH.

J Biol Chem. 1995 Jun 2;270(22):13503-11.

39.

Electroporation of antibodies into mammalian cells.

Campbell PL, McCluskey J, Yeo JP, Toh BH.

Methods Mol Biol. 1995;48:83-92. No abstract available.

PMID:
8528411
40.

Antigen presentation and assembly by mouse I-Ak class II molecules in human APC containing deleted or mutated HLA DM genes.

Brooks AG, Campbell PL, Reynolds P, Gautam AM, McCluskey J.

J Immunol. 1994 Dec 15;153(12):5382-92.

PMID:
7989744
41.
42.

Rapid induction of human alpha, beta and gamma globin genes in transiently transfected mouse erythroleukemia cells.

Jones RW, Campbell PL, Kulozik AE, Woodham JP.

Prog Clin Biol Res. 1989;316B:197-208. No abstract available.

PMID:
2616575
43.

A trial of propranolol in chronic schizophrenia.

Myers DH, Campbell PL, Cocks NM, Flowerdew JA, Muir A.

Br J Psychiatry. 1981 Aug;139:118-21. No abstract available.

PMID:
7030444
45.

COMPARATIVE EFFECTS OF VARIOUS ANALOGUES OF THYROXINE ON AMINO ACID INCORPORATION INTO PROTEIN.

CAMPBELL PL, DEIBLER GE, GELBER S, SOKOLOFF L.

Endocrinology. 1964 Sep;75:304-11. No abstract available.

PMID:
14235396
46.

THYROXINE STIMULATION OF AMINO ACID INCORPORATION INTO PROTEIN INDEPENDENT OF ANY ACTION ON MESSENGER RNA SYNTHESIS.

SOKOLOFF L, FRANCIS CM, CAMPBELL PL.

Proc Natl Acad Sci U S A. 1964 Sep;52:728-36. No abstract available.

47.

EFFECTS OF L-THYROXINE ON AMINO ACID INCORPORATION INTO PROTEIN IN MATURE AND IMMATURE RAT BRAIN.

GELBER S, CAMPBELL PL, DEIBLER GE, SOKOLOFF L.

J Neurochem. 1964 Apr;11:221-9. No abstract available.

PMID:
14152519
48.

THYROXINE STIMULATION OF AMINO ACID INCORPORATION INTO RIBOSOMAL PROTEIN.

SOKOLOFF L, CAMPBELL PL, FRANCIS CM, KLEE CB.

Biochim Biophys Acta. 1963 Oct 15;76:329-32. No abstract available.

PMID:
14097394
49.

Thyroxine stimulation of amino acid incorporation into protein. Localization of stimulated step.

SOKOLOFF L, KAUFMAN S, CAMPBELL PL, FRANCIS CM, GELBOIN HV.

J Biol Chem. 1963 Apr;238:1432-7. No abstract available.

50.

Effects of salicylate on amino acid incorporation into protein.

WEISS WP, CAMPBELL PL, DEIBLER GE, SOKOLOFF L.

J Pharmacol Exp Ther. 1962 Jun;136:366-71. No abstract available.

PMID:
14005904

Supplemental Content

Loading ...
Support Center